Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Uemura

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|January 6, 2012
Hepatocellular carcinomaJames J Yeh, Marc Uemura
Case Reports in Hematology|September 28, 2013
Hemophagocytic Lymphohistiocytosis Complicating T-Cell Lymphoma in a Patient with HIV InfectionMarc Uemura, Richard Huynh, Allen Kuo, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 24, 2013
Enhancing quality improvements in cancer care through CME activities at a nationally recognized cancer centerMarc Uemura, Robert Morgan, Mary Mendelsohn, et al.
Annals of the Rheumatic Diseases|August 24, 2017
Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case seriesSang Taek Kim, Jean Tayar, Van Anh Trinh, et al.
Journal of Hematology & Oncology|September 7, 2016
Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn's disease: a case reportMarc Uemura, Van A Trinh, Cara Haymaker, et al.
BMC Cancer|May 17, 2017
Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgeryMarc Uemura, Wei Qiao, Keith Fournier, et al.
Journal for Immunotherapy of Cancer|January 25, 2017
Erratum to: A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1Marc Uemura, Faisal Fa'ak, Cara Haymaker, et al.
Journal for Immunotherapy of Cancer|September 24, 2016
A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1Marc Uemura, Faisal Fa'ak, Cara Haymaker, et al.
Cancer Immunology Research|January 8, 2017
Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 BlockadeCara L Haymaker, DaeWon Kim, Marc Uemura, et al.
Journal of Cutaneous Pathology|September 14, 2017
Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patientsMichael T Tetzlaff, Amir A Jazaeri, Carlos A Torres-Cabala, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|January 6, 2012
Hepatocellular carcinomaJames J Yeh, Marc Uemura
Case Reports in Hematology|September 28, 2013
Hemophagocytic Lymphohistiocytosis Complicating T-Cell Lymphoma in a Patient with HIV InfectionMarc Uemura, Richard Huynh, Allen Kuo, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 24, 2013
Enhancing quality improvements in cancer care through CME activities at a nationally recognized cancer centerMarc Uemura, Robert Morgan, Mary Mendelsohn, et al.
Annals of the Rheumatic Diseases|August 24, 2017
Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case seriesSang Taek Kim, Jean Tayar, Van Anh Trinh, et al.
Journal of Hematology & Oncology|September 7, 2016
Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn's disease: a case reportMarc Uemura, Van A Trinh, Cara Haymaker, et al.
BMC Cancer|May 17, 2017
Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgeryMarc Uemura, Wei Qiao, Keith Fournier, et al.
Journal for Immunotherapy of Cancer|January 25, 2017
Erratum to: A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1Marc Uemura, Faisal Fa'ak, Cara Haymaker, et al.
Journal for Immunotherapy of Cancer|September 24, 2016
A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1Marc Uemura, Faisal Fa'ak, Cara Haymaker, et al.
Cancer Immunology Research|January 8, 2017
Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 BlockadeCara L Haymaker, DaeWon Kim, Marc Uemura, et al.
Journal of Cutaneous Pathology|September 14, 2017
Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patientsMichael T Tetzlaff, Amir A Jazaeri, Carlos A Torres-Cabala, et al.
Pageof 2